NeoGenomics Inc (NEO) reports robust revenue growth and improved margins, while navigating challenges in the pharma segment and ongoing litigation.

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced plans to release its fourth quarter and full year 2024 ...

Despite a challenging revenue environment, iQIYI Inc (IQ) focuses on premium content, mini-dramas, and international expansion to drive future growth.

Delivered an outstanding year of growth and profitability. We finished 2024 on a strong note, with double-digit revenue growth and a 20.0% ...

Array Technologies Q4 earnings on Feb. 27 could bring key insights. Read here for valuation appeal, resilient margins and ...

Q1 2025 Management View Andrew Kiguel, CEO, emphasized a significant pivot to AI and robotics, leading to a "big increase in revenue" for Q1 2025. The company attributed net income growth to ...

We recently published a list of 10 S&P 500 Stocks That Outperformed Bitcoin in 2024. In this article, we are going to take a ...

Q4 2024 Management View CEO Lasse Petterson highlighted that Great Lakes achieved its second-highest financial performance in 135 years, with Q4 revenues of $202.8 million and adjusted EBITDA of $40.2 ...

Sapiens International Corporation N.V. (NASDAQ:SPNS) Q4 2024 Management View Sapiens reported Q4 2024 revenue of $134M, reflecting a 2.6% increase year-over-year. CEO Roni Al-Dor highlighted key ...

Grand Canyon Education (NASDAQ:LOPE) is scheduled to announce Q4 earnings results on Wednesday, February 19th, after market close. The consensus EPS Estimate is $2.94 (+6.1% Y/Y) and the consensus ...

Analyst consensus estimates for the quarter provided by FactSet. YOY = Year over year. pps = Percentage points. Overview of ...

Cadence Design Systems (NASDAQ:CDNS) easily surpassed market expectations with its fourth quarter 2024 results, but the ...